4
Changes in Ownership
BOSTON SCIENTIFIC CORP Filed Acc 0001225208-24-006325
EVP and CFO sold 112,075 shares at an average $75.57 ($8,469,752)
- EVP and CFO acquired 64,454 shares (option exercise)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
Brennan Daniel J. · EVP and CFO
Table I: Non-derivative
6 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2024-05-22 | Exercise or conversion : show line 1 in the form 10b5-1 | +16,863 | $24.55 | $413,987 | 288,405 | D |
| 2024-05-22 | Exercise or conversion : show line 2 in the form 10b5-1 | +16,863 | $17.26 | $291,055 | 305,268 | D |
| 2024-05-22 | Exercise or conversion : show line 3 in the form 10b5-1 | +15,642 | $27.09 | $423,742 | 320,910 | D |
| 2024-05-22 | Exercise or conversion : show line 4 in the form 10b5-1 | +15,086 | $16.31 | $246,053 | 335,996 | D |
| 2024-05-22 | Sale : show line 5 in the form 10b5-1 | −64,454 | $75.91 | $4,892,819 | 271,542 | D |
| 2024-05-23 | Sale : show line 6 in the form 10b5-1 | −47,621 | $75.11 | $3,576,932 | 223,921 | D |
| Open-market sales · 112,075 sh · avg $75.57 · $8,469,752 | ||||||
Table II: Derivative
4 lines| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2024-05-22 | Exercise or conversion : show line 7 in the form 10b5-1 Stock Option (Right to Buy) | −15,642 | 46,927 | D |
| 2024-05-22 | Exercise or conversion : show line 8 in the form 10b5-1 Stock Option (Right to Buy) | −16,863 | 16,865 | D |
| 2024-05-22 | Exercise or conversion : show line 9 in the form 10b5-1 Stock Option (Right to Buy) | −15,086 | 15,087 | D |
| 2024-05-22 | Exercise or conversion : show line 10 in the form 10b5-1 Stock Option (Right to Buy) | −16,863 | 55,600 | D |
Loading xslF345X05/doc4.xml…